Health Catalyst sells Vitalware to Med-Metrix for $147M; plans to repay term loan

Health Catalyst, Inc.

Sale price of $147M in cash, subject to customary adjustments; expected close in Q3 2026.
Net proceeds plus cash on hand to repay ~$160M senior secured term loan, including prepayment premiums.
Vitalware generated ~$37M in FY 2025 revenue; transaction sharpens focus on AI and core technology.
Closing conditions include HSR clearance and ≥80% of Vitalware employees accepting job offers from buyer.

item 1.01 item 7.01 item 9.01

Featured in Daily 8-K Digest

Selected #7 for 2026-06-04. Read digest

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Health Catalyst, Inc. entered into Unit Purchase Agreement with Med-Metrix, LLC valued at $147 million (effective 2026-06-04).

Action: entry
Agreement: asset purchase
Counterparty: Med-Metrix, LLC
Value: $147 million
Effective: 2026-06-04

Exact text from the filing

On June 4, 2026, Health Catalyst, Inc. ("Health Catalyst") entered into a Unit Purchase Agreement (the "Purchase Agreement") with Med-Metrix, LLC ("Buyer")

View on SEC.gov

284 material agreements filed in the last 30 days. Browse all material agreements →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-26-000082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.